Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging

Nature Communications

Volumn 5, Issue , 2014, Pages

  Sowers, Molly A ^a   Mccombs, Jessica R ^a   Wang, Ying ^b   Paletta, Joseph T ^b   Morton, Stephen W ^c   Dreaden, Erik C ^c   Boska, Michael D ^d   Francesca Ottaviani, M ^e   Hammond, Paula T ^c   Rajca, Andrzej ^b   Johnson, Jeremiah A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e UNIVERSITY OF URBINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BRANCHED BOTTLEBRUSH POLYMER; CONTRAST MEDIUM; NANOMATERIAL; NITROXIDE; POLYMER; UNCLASSIFIED DRUG; NITROGEN OXIDE; NITROXYL;

CONCENTRATION (COMPOSITION); FLUORESCENCE; HEAVY METAL; IMAGING METHOD; MOLECULAR ANALYSIS; POLYMER; REDOX CONDITIONS;

ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FLUORESCENCE IMAGING; IN VITRO STUDY; IN VIVO STUDY; LONGITUDINAL STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION REACTION; RELAXATION TIME; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DEVICES; FLUORESCENCE; HELA CELL LINE; HUMAN; SYNTHESIS;

CALLISTEMON; MUS;

ANIMALS; ASCORBIC ACID; CONTRAST MEDIA; FEMALE; FLUORESCENCE; HELA CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MOLECULAR IMAGING; NITROGEN OXIDES; OXIDATION-REDUCTION; POLYMERS;

EID: 84923338789     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6460     Document Type: Article

References (70)

1. Doane, T. L. & Burda, C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem. Soc. Rev. 41, 2885-2911 (2012).
2. Boase, N. R. B., Blakey, I. & Thurecht, K. J. Molecular imaging with polymers. Polym. Chem. 3, 1384-1389 (2012).
3. Thurecht, K. J. Polymers as probes for multimodal imaging with MRI. Macromol. Chem. Phys. 213, 2567-2572 (2012).
4. Shellock, F. G. & Kanal, E. Safety of magnetic resonance imaging contrast agents. J. Magn. Reson. Imaging 10, 477-484 (1999).
5. Villaraza, A. J. L., Bumb, A. & Brechbiel, M. W. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem. Rev. 110, 2921-2959 (2010).
6. van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat. Med. 17, 1315-1319 (2011).
7. Ghoroghchian, P. P. et al. Near-infrared-emissive polymersomes: selfassembled soft matter for in vivo optical imaging. Proc. Natl Acad. Sci. USA 102, 2922-2927 (2005).
8. Deng, Z. J. et al. Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano 7, 9571-9584 (2013).
9. Zhang, X. A., Lovejoy, K. S., Jasanoff, A. & Lippard, S. J. Water-soluble porphyrins imaging platform for MM zinc sensing. Proc. Natl Acad. Sci. USA 104, 10780-10785 (2007).
10. You, Y. M. et al. Manganese displacement from Zinpyr-1 allows zinc detection by fluorescence microscopy and magnetic resonance imaging. Chem. Commun. 46, 4139-4141 (2010).
11. Zhang, X. L. et al. Dual-functional gadolinium-based copper(II) probe for selective magnetic resonance imaging and fluorescence sensing. Inorg. Chem. 51, 2325-2331 (2012).
12. Jang, J. H. et al. Cu2-responsive bimodal (Optical/MRI) contrast agent for cellular imaging. Org. Lett. 15, 4702-4705 (2013).
13. Tu, C., Nagao, R. & Louie, A. Y. Multimodal magnetic-resonance/opticalimaging contrast agent sensitive to NADH. Angew. Chem. Int. Ed. 48, 6547-6551 (2009).
14. Medarova, Z., Pham, W., Farrar, C., Petkova, V. & Moore, A. In vivo imaging of siRNA delivery and silencing in tumors. Nat. Med. 13, 372-377 (2007).
15. Koyama, Y. et al. A dendrimer-based nanosized contrast agent, dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J. Magn. Reson. Imaging 25, 866-871 (2007).
16. Kelly, K. A. et al. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med. 5, 657-668 (2008).
17. Olson, E. S. et al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc. Natl Acad. Sci. USA 107, 4311-4316 (2010).
18. Dai, Y. L. et al. In vivo multimodality imaging and cancer therapy by nearinfrared light-triggered trans-platinum pro-drug-conjugated upconverison nanoparticles. J. Am. Chem. Soc. 135, 18920-18929 (2013).
19. Hu, J. M., Liu, T., Zhang, G. Y., Jin, F. & Liu, S. Y. Synergistically enhance magnetic resonance/fluorescence imaging performance of responsive polymeric nanoparticles under mildly acidic biological milieu. Macromol. Rapid Commun. 34, 749-758 (2013).
20. Jiang, L. Y. et al. pH/temperature sensitive magnetic nanogels conjugated with Cy5.5-labled lactoferrin for MR and fluorescence imaging of glioma in rats. Biomaterials 34, 7418-7428 (2013).
21. Rolfe, B. E. et al. Multimodal polymer nanoparticles with combined 19 F magnetic resonance and optical detection for tunable, targeted, multimodal imaging in vivo. J. Am. Chem. Soc. 136, 2413-2419 (2014).
22. Davies, G. L., Kramberger, I. & Davis, J. J. Environmentally responsive MRI contrast agents. Chem. Commun. 49, 9704-9721 (2013).
23. Lauffer, R. B. Paramagnetic metal-complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 87, 901-927 (1987).
24. Terreno, E., Delli Castelli, D., Viale, A. & Aime, S. Challenges for molecular magnetic resonance imaging. Chem. Rev. 110, 3019-3042 (2010).
25. Swaminathan, S. et al. Nephrogenic systemic fibrosis, gadolinium, and iron mobilization. New Engl. J. Med. 357, 720-722 (2007).
26. Braverman, I. & Cowper, S. Nephrogenic systemic fibrosis. F1000 Med. Rep. 2, 84 (2010).
27. Wang, K. W., Peng, H., Thurecht, K. J., Puttick, S. & Whittaker, A. K. Biodegradable core crosslinked star polymer nanoparticles as F-19 MRI contrast agents for selective imaging. Polym. Chem. 5, 1760-1771 (2014).
28. Chen, S. Z., Yang, Y. Q., Li, H. D., Zhou, X. & Liu, M. L. pH-Triggered Au-fluorescent mesoporous silica nanoparticles for F-19 MR/fluorescent multimodal cancer cellular imaging. Chem. Commun. 50, 283-285 (2014).
29. Brasch, R. C. et al. Brain nuclear magnetic-resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary-report. Am. J. Roentgenol. 141, 1019-1023 (1983).
30. Zhelev, Z. et al. Nitroxyl radicals for labeling of conventional therapeutics and noninvasive magnetic resonance imaging of their permeability for blood-brain barrier: relationship between structure, blood clearance, and MRI signal dynamic in the brain. Mol. Pharm. 6, 504-512 (2009).
31. Rajca, A. et al. Organic radical contrast agents for magnetic resonance imaging. J. Am. Chem. Soc. 134, 15724-15727 (2012).
32. Rajca, A. et al. Correction to organic radical contrast agents for magnetic resonance imaging. J. Am. Chem. Soc. 136, 3318-3318 (2014).
33. Samuni, Y. et al. Factors influencing nitroxide reduction and cytotoxicity in vitro. Antioxid. Redox Signal. 6, 587-595 (2004).
34. Vianello, F., Momo, F., Scarpa, M. & Rigo, A. Kinetics of nitroxide spin-label removal in biological-systems: an in vitro and in vivo ESR study. Magn. Reson. Imaging 13, 219-226 (1995).
35. Bobko, A. A., Kirilyuk, I. A., Grigor'ev, I. A., Zweier, J. L. & Khramtsov, V. V. Reversible reduction of nitroxides to hydroxylamines: roles for ascorbate and glutathione. Free Radic. Biol. Med. 42, 404-412 (2007).
36. Hyodo, F., Matsumoto, K., Matsumoto, A., Mitchell, J. B. & Krishna, M. C. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. Cancer Res. 66, 9921-9928 (2006).
37. Matsumoto, K. et al. High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin. Cancer Res. 12, 2455-2462 (2006).
38. Utsumi, H. et al. Simultaneous molecular imaging of redox reactions monitored by overhauser-enhanced MRI with N-14-and N-15-labeled nitroxyl radicals. Proc. Natl Acad. Sci. USA 103, 1463-1468 (2006).
39. Davis, R. M. et al. A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector. Free Radic. Biol. Med. 51, 780-790 (2011).
40. Francese, G., Dunand, F. A., Loosli, C., Merbach, A. E. & Decurtins, S. Functionalization of PAMAM dendrimers with nitronyl nitroxide radicals as models for the outer-sphere relaxation in dentritic potential MRI contrast agents. Magn. Reson. Chem. 41, 81-83 (2003).
41. Winalski, C. S. et al. Targeted dendrimer-based contrast agents for articular cartilage assessment by MR imaging. Osteoarthritis Cartilage 16, 815-822 (2008).
42. Winalski, C. S., Shortkroff, S., Mulkern, R. V., Schneider, E. & Rosen, G. M. Magnetic resonance relaxivity of dendrimer-linked nitroxides. Magn. Reson. Med. 48, 965-972 (2002).
43. Stryer, L. & Griffith, O. H. A spin-labeled hapten. Proc. Natl Acad. Sci. USA 54, 1785-1791 (1965).
44. Blinco, J. P., Fairfull-Smith, K. E., Morrow, B. J. & Bottle, S. E. Profluorescent nitroxides as sensitive probes of oxidative change and free radical reactions. Aust. J. Chem. 64, 373-389 (2011).
45. Medvedeva, N., Martin, V. V., Weis, A. L. & Likhtenshten, G. I. Dual fluorophore-nitronyl probe for investigation of superoxide dynamics and antioxidant status of biological systems. J. Photochem. Photobiol. A 163, 45-51 (2004).
46. Morrow, B. J., Keddie, D. J., Gueven, N., Lavin, M. F. & Bottle, S. E. A novel profluorescent nitroxide as a sensitive probe for the cellular redox environment. Free Radic. Biol. Med. 49, 67-76 (2010).
47. Yapici, N. B. et al. New rhodamine nitroxide based fluorescent probes for intracellular hydroxyl radical identification in living cells. Org. Lett. 14, 50-53 (2012).
48. Ahn, H. Y. et al. Two-photon fluorescence microscopy imaging of cellular oxidative stress using profluorescent nitroxides. J. Am. Chem. Soc. 134, 4721-4730 (2012).
49. Yang, Y. M., Zhao, Q., Feng, W. & Li, F. Y. Luminescent chemodosimeters for bioimaging. Chem. Rev. 113, 192-270 (2013).
50. Coenjarts, C. et al. Mapping photogenerated radicals in thin polymer films: fluorescence imaging using a prefluorescent radical probe. J. Am. Chem. Soc. 125, 620-621 (2003).
51. Micallef, A. S. et al. The application of a novel profluorescent nitroxide to monitor thermo-oxidative degradation of polypropylene. Polym. Degrad. Stab. 89, 427-435 (2005).
52. Johnson, J. A. et al. Drug-loaded, bivalent-bottle-brush polymers by graft-through ROMP. Macromolecules 43, 10326-10335 (2010).
53. Burts, A. O. et al. Using EPR to compare PEG-branch-nitroxide ''bivalentbrush polymers'' and traditional PEG bottle-brush polymers: branching makes a difference. Macromolecules 45, 8310-8318 (2012).
54. Leitgeb, A., Wappel, J. & Slugovc, C. The ROMP toolbox upgraded. Polymer 51, 2927-2946 (2010).
55. Paletta, J. T., Pink, M., Foley, B., Rajca, S. & Rajca, A. Synthesis and reduction kinetics of sterically shielded pyrrolidine nitroxides. Org. Lett. 14, 5322-5325 (2012).
56. Joralemon, M. J., Mcrae, S. & Emrick, T. PEGylated polymers for medicine: from conjugation to self-assembled systems. Chem. Commun. 46, 1377-1393 (2010).
57. Xia, Y. et al. EPR study of spin labeled brush polymers in organic solvents. J. Am. Chem. Soc. 133, 19953-19959 (2011).
58. Liu, J. et al. ''Brush-first'' method for the parallel synthesis of photocleavable, nitroxide-labeled poly(ethylene glycol) star polymers. J. Am. Chem. Soc. 134, 16337-16344 (2012).
59. Torchilin, V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 63, 131-135 (2011).
60. Keana, J. F. W., Pou, S. & Rosen, G. M. Nitroxides as potential contrast enhancing agents for mri application: influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular-fractions, and ascorbate. Mag. Res. Med. 5, 525-536 (1987).
61. Levine, M., Padayatty, S. J. & Espey, M. G. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv. Nutr. 2, 78-88 (2011).
62. Khramtsov, V. V., Bobko, A. A., Kirilyuk, I. A., Grigor'ev, I. A. & Zweier, J. L. New insight into the mechanism of the redox equilibrium of the nitroxidehydroxylamine couple: the roles for ascorbate and glutathione. Free Radic. Biol. Med. 37, S15-S15 (2004).
63. Miki, K. et al. Ring-opening metathesis polymerization-based synthesis of ICG-containing amphiphilic triblock copolymers for in vivo tumor imaging. Bioconjug. Chem. 20, 511-517 (2009).
64. Miki, K. et al. High-contrast fluorescence imaging of tumors in vivo using nanoparticles of amphiphilic brush-like copolymers produced by ROMP. Angew. Chem. Int. Ed. 50, 6567-6570 (2011).
65. Gueugnon, F. et al. Nanoparticles produced by ring-opening metathesis polymerization using norbornenyl-poly(ethylene oxide) as a ligand-free generic platform for highly selective in vivo tumor targeting. Biomacromolecules 14, 2396-2402 (2013).
66. Workman, P. et al. Guidelines for the welfare and use of animals in cancer research. Br. J. Cancer 102, 1555-1577 (2010).
67. Chapman, K. et al. A global pharmaceutical company initiative: An evidencebased approach to define the upper limit of body weight loss in short term toxicity studies. Regul. Toxicol. Pharmacol. 67, 27-38 (2013).
68. Vissers, M. C. M., Bozonet, S. M., Pearson, J. F. & Braithwaite, L. J. Dietary ascorbate intake affects steady state tissue concentrations in vitamin C-deficient mice: tissue deficiency after suboptimal intake and superior bioavailability from a food source (kiwifruit). Am. J. Clin. Nutr. 93, 292-301 (2011).
69. Parsons, K. K., Maeda, N., Yamauchi, M., Banes, A. J. & Koller, B. H. Ascorbic acid-independent synthesis of collagen in mice. Am. J. Physiol. Endocrinol. Metab. 290, E1131-E1139 (2006).
70. Liao, L. et al. A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled released of cisplatin, doxorubicin, and camptothecin. J. Am. Chem. Soc. 136, 5896-5899 (2014).